chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up report (s) previously submitted on 5/12/2006. Information has been received from a registered nurse concerning an elementary school-aged child who on 30-JUL-1997 was vaccinated with a dose of VARIVAX (Merck). On 01-MAR-2006, the patient developed breakthrought chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 24-SEP-1997 was vaccinated with a dose of varicella virus vaccine live. On 01-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available.   Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular, Viral infection
Clinical narrative: Information has been received from a RN concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approx 23Feb06, the pt developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received from a registered nurse concerning an elementary school-aged child who on 12-FEB-1999 was vaccinated with a dose of VARIVAX (Merck). On 21-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Vaccination failure, Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/12/2006.  Information has been received from a registered nurse concerning an elementary school-aged child who on 22-FEB-1999 was vaccinated with a dose of VARIVAX (Merck).  On 05-MAR-2006, the patient developed breakthrough chickenpox.  Unspecified medical attention was sought.  There was no product quality complaint involved.  No further information was available.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved.   No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received froma registered nurse concerning an elementary school-aged child who on 18-MAY-2006, the patient developed breakthrough chickenpox. Unsupecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additionsl information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of VARIVAX (Merck). On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 21-JUL-1999 was vaccinated with a dose of varicella virus vaccine live. On 21-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 21-MAR-2000 was vaccinated with a dose of varicella virus vaccine live. On 04-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report(s) previously submitted on 5/12/2006. Information has been receive from a registered nurse concerning an elementary school-aged child who on 20-JUN-2000 was vaccinated with a dose of VARIVAX (Merck). On 04-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On 02-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 18-JUL-2000 was vaccinated with a dose of varicella virus vaccine live. On 02-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received from a registered nurst concerning an elementary school-aged child lwho on 26-JUL-2000 was vaccinated with a dose of VARIVAX (Merck). On 01-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medica; attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 27-JUL-2000 was vaccinated with a dose of varicella virus vaccine live. On 03-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 04-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received from a registered nurse concerning an elementary school-aged child on 23-JAn-2001 was vaccinated with a dose of VARIVAX (Merck). ON 02-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 02-MAY-2001 was vaccinated with a dose of varicella virus vaccine live. On approximately 28-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who on 14-JUN-2001 was vaccinated with a dose of VARIVAX. On 01-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006 Information has been received from a registered nurse concerning an elementary school-aged child who on 17-SEP-2001 was vaccinated with a dose of VARIVAX (Merck). On 02-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an elementary school aged child who was vaccinated with a dose of varicella virus vaccine live. On approximately 23-FEB-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been recieived froma  registered nurse concerning an elementary school-aged child who on 22-FEB-2001 was vaccinated with a dose of VARIVAX (Merck). On 03-MAR-2006, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint involved. No further information was available. Additional information has been requested.
Age: 41.0
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Laboratory test abnormal, Neuralgia, Urticaria, Viral infection
Clinical narrative: Information has been received from a physician concerning a 41 year old female with a history of negative varicella titer who in 1999 was vaccinated SC with a 0.5 ml dose of varicella virus vaccine live. There was no concomitant medication. In 1999, within 24 hours of receiving the vaccine, the patient experienced hives around her joints. Soon after this, in approximately 1999, she broke out in a chickenpox like rash for which she was treated with cetirizine hydrochloride (ZYRTEC). Since then the patient has had 3 episodes of "zoster" (type unspecified) per year for which she is treated with cetirizine hydrochloride (ZYRTEC), montelukast sodium (MSD) and albuterol. The zoster lesions most recently appeared on her face and previously on her hip. She also has post herpetic neuralgia. It was noted that she is presently being treated with medications. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a child who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed breakthrough chickenpox. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Age: 1.05
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous, Headache, Nausea, Pruritus
Clinical narrative: Information has been received from a health professional concerning a 7 year old male female who on 04-JAN-2000 was vaccinated SC with a 0.5 ml dose of varicella virus vaccine live (lot# 631773/1033J). On 14-MAR-2006 the patient presented with 15 - 20 vesicular lesions on her trunk and face, nausea, itching and a headache. The patient was treated with over the counter acetaminophen (TYLENOL) as needed. unspecified medical attention was sought. At the time of the report, the patient was recovering. There was no product quality complaint involved. Additional information has been requested. This information is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received from a health professinal concerning a 7 year old white female with no allergies or medical conditions who on 04-JAN-2000 was vaccinated SC with a 0.5 ml first dose of VARIVAX (Merck) (631773/1033J). There was no illness at the time of vaccination. ON 14-MAR-2006 the patient presented with 15-20 vesicular lesions on her and face , nausea, itching and headache. The patient was treated with over the counter TYLENOL as needed. Unspecified medical attention was sought. At the time of the report, the patient was recovering. There was no product quality complaint involved. Follow up information received indicated that on 14-MAR-2006 the patient was seen with spots all over the body that were itchy. There were 15-20 spots on the trunk, scattered spots on the forehead and the arms and legs. There were spots in the mouth and throat that were causing her throat to be sore. She had headaches and nausea. It was noted that the patient had chicken pox. No labs were done and the patient recovered. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a child who was vaccinated with a dose of varicella virus vaccine live. It was reported that the patient experienced breakthrough chickenpox sometime from 27-FEB to the present, 17-MAR-2006. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema
Clinical narrative: Information has been received from a health professional concerning a 15 year old female with no allergies and no medical history who on 15-MAR-2006 was vaccinated SC with a 0.5ml first dose of varicella virus vaccine love (lot# 652454/1017R). There was no concomitant medication. On 17-MAR-2006 the patient experienced a red area around injection site the size of a quarter. It was also reported that there was no redness, no warmth and no pain. Unspecified medical attention was sought, but no treatment was provided and no labs were done. At the time of reporting the patient had not recovered. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/12/2006. Information has been received from a health professional concerning a 15 year old female with no allergies and no medical history who on 15-MAR-2006 was vaccinated SC in the left arm with a 0.5ml first dose of VARIVAX (Merck) (lot#652454/1017R). There was no concomitant medication and no illnesses at the time of vaccination. On 17-MAR-2006 the patient experienced a red area aroung injection site the size of a quarter. It was also reported that there was no redness, no warmth and no pain. Unspecified medical attention was sought, but no treatment was provided and no labs were done. At the time of reporting the patient had not recovered. Follow up information froma health professional indicated that the patient had erythema approximately the size of a quarter the the injectionsite that increased in size to a half dollar. there was no pain or fever. She saw her primary physicianon 19-MAR-2006 for evaluationand no intervention was ordered. The patient recovered on an unknown date. Additionally information is not expected.
Age: 7.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 7 year old female who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 6 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning an elementary age male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning an 8 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 5 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. Unspecified medical attention was sought and the patient's breakthrough was confirmed. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a female in the 5th grade who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a patient in the fourth grade who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a male in the 8th grade who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a male in the 3rd grade who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Infection transmission via personal contact, Viral infection
Clinical narrative: Information has been received from a physician concerning a 12 month old who was not vaccinated with a does of varicella virus vaccine live developed chickenpox after her 5 year old sister was vaccinated with a dose of varicella virus vaccine live (WAES0509USA04305). No date of onset was reported. It was unspecified if medical attention was sought. No further information was available at the time of this report. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a child who was vaccinated with a does of varicella virus vaccine live. It was reported that the patient experienced breakthrough chickenpox sometime from 27-FEB-2006 to the present, 17-MAR-2006. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a child who was vaccinated with a dose of varicella virus vaccine live. it was reported that the patient experienced breakthrough chickenpox sometime from 27-FEB-2006 to the present, 17-MAR-2006. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chickenpox. Unspecified medical attention was sought. the patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chickenpox. Unspecified medical attention was sought. the patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chicken pox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced a mild case of chicken pox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5- 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chicken pox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced a mild case of chicken pox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chickenpox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved.  Additional information has been requested.
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient experienced a mild case of chickenpox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a physician concerning a kid who was vaccinated with a dose of varicella virus vaccine live. On approximately 25-FEB-2006 the patient experienced varicella breakthrough. Unspecified medical attention was sought. There was product quality complaint involved. Additional information has been requested.
Age: 1.01
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old white male with known medical history or allergies who who 17-OCT-2000 was vaccinated SC with a first dose of varicella virus vaccine live (lot # 635981/0447K). There was no illness at the time of vaccination. In February 2006, the patient developed a mild breakthrough case, characterized by a rash with less than 50 lesions. There was no fever. Unspecified medical attention was sought. The rash lasted about two days. Subsequently, the patient recovered. There was no product quality complaint involved. Additional information is not expected.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Blister
Clinical narrative: Information has been received from a health professional concerning an 8 year old male with no known medical history who was vaccinated at 12 months of age with a does of varicella virus vaccine live. There was no concomitant medication. In February 2006, the patient developed breakthrough with less than 50 vesicles on torso and thorax. Unspecified medical attention was sought. The patient recovered on an unspecified date. There was no product quality complaint involved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 6 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was not known. There was no product quality complaint involved. Additional information has been requested.
Age: 7.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 7 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was not known. There was no product quality complaint involved. Additional information has been requested.
Age: 8.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a registered nurse concerning an 8 year old male who was vaccinated with a dose of varicella virus vaccine live.  Subsequently the patient developed mild breakthrough varicella. It is unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 6.0
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 6 year old patient who was vaccinated with a dose of varicella virus live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint involved. Additional information has been requested.
Age: 6.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 6 year old female who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. It was unknown if medical attention was sought. The patient's outcome was unknown. There was no product quality complaint. Additional information has been requested.
Age: 48.0
Sex: F
Vaccine: HEPA, IPV, MEN, PPV, TYP, YF, HEPA, IPV, MNQ, PPV, TYP, HEPA, IPV, TYP, YF
Symptoms: Chills, Musculoskeletal stiffness, Pyrexia, Shoulder pain, Tremor
Clinical narrative: Initial report received on 04May06 from a health care professional. A 48 yr old female pt, who was traveling out of the country, and whose medical history includes mild inflammatory bowel disease, which had not been diagnosed as either Crohn's disease or ulcerative colitis, had received her first dose of YF Vax vaccine, Typhim VI vaccine, poliomyelitis inactivated vaccine, and hep A vaccine on 01May06. On 03May06, the pt subsequently received additional immunizations with her first dose of Meningococcal vaccine and pneumococcal vaccine. The trade names, manf lot numbers, routes and sites of administration were not reported for any of the vaccines. Two hours post immunization on 03May06, the pt developed shaking chills, muscle aches, a sore neck and fever. She was seen in the ER and treated with IV fluids and an unk antibiotic. A CBC was completed and her WBC's were 12,000. Her chemistry test was normal, except for a low serum sodium level of 131. A lumbar puncture was not done. At the time of this report, the pt had been under observation in the ER for more than 24 hrs. The reporter stated that she was in the process of trying to get the pt transferred from the rural hospital ER to a higher level hospital. The reporter was concerned that the events were related to the YF Vax immunization. The pt had not recovered from these events at the time of this report.
Age: 48.0
Sex: F
Vaccine: HEPA, IPV, MEN, PPV, TYP, YF, HEPA, IPV, MNQ, PPV, TYP, HEPA, IPV, TYP, YF
Symptoms: Abdominal pain upper, Chills, Hyperventilation, Injection site hypersensitivity, Injection site pain
Clinical narrative: Initial report received on 04May06 from a health care professional. A 48 yr old female pt, who was traveling out of the country, and whose medical history includes mild inflammatory bowel disease, which had not been diagnosed as either Crohn's disease or ulcerative colitis, had received her first dose of YF Vax vaccine, Typhim VI vaccine, poliomyelitis inactivated vaccine, and hep A vaccine on 01May06. On 03May06, the pt subsequently received additional immunizations with her first dose of Meningococcal vaccine and pneumococcal vaccine. The trade names, manf lot numbers, routes and sites of administration were not reported for any of the vaccines. Two hours post immunization on 03May06, the pt developed shaking chills, muscle aches, a sore neck and fever. She was seen in the ER and treated with IV fluids and an unk antibiotic. A CBC was completed and her WBC's were 12,000. Her chemistry test was normal, except for a low serum sodium level of 131. A lumbar puncture was not done. At the time of this report, the pt had been under observation in the ER for more than 24 hrs. The reporter stated that she was in the process of trying to get the pt transferred from the rural hospital ER to a higher level hospital. The reporter was concerned that the events were related to the YF Vax immunization. The pt had not recovered from these events at the time of this report.
Age: 48.0
Sex: F
Vaccine: HEPA, IPV, MEN, PPV, TYP, YF, HEPA, IPV, MNQ, PPV, TYP, HEPA, IPV, TYP, YF
Symptoms: Neck pain, Pain, Pyrexia, Rash, Tremor
Clinical narrative: Initial report received on 04May06 from a health care professional. A 48 yr old female pt, who was traveling out of the country, and whose medical history includes mild inflammatory bowel disease, which had not been diagnosed as either Crohn's disease or ulcerative colitis, had received her first dose of YF Vax vaccine, Typhim VI vaccine, poliomyelitis inactivated vaccine, and hep A vaccine on 01May06. On 03May06, the pt subsequently received additional immunizations with her first dose of Meningococcal vaccine and pneumococcal vaccine. The trade names, manf lot numbers, routes and sites of administration were not reported for any of the vaccines. Two hours post immunization on 03May06, the pt developed shaking chills, muscle aches, a sore neck and fever. She was seen in the ER and treated with IV fluids and an unk antibiotic. A CBC was completed and her WBC's were 12,000. Her chemistry test was normal, except for a low serum sodium level of 131. A lumbar puncture was not done. At the time of this report, the pt had been under observation in the ER for more than 24 hrs. The reporter stated that she was in the process of trying to get the pt transferred from the rural hospital ER to a higher level hospital. The reporter was concerned that the events were related to the YF Vax immunization. The pt had not recovered from these events at the time of this report.
Age: 48.0
Sex: F
Vaccine: HEPA, IPV, MEN, PPV, TYP, YF, HEPA, IPV, MNQ, PPV, TYP, HEPA, IPV, TYP, YF
Symptoms: Blood sodium decreased, Chills, Myalgia, Neck pain, Pyrexia
Clinical narrative: Initial report received on 04May06 from a health care professional. A 48 yr old female pt, who was traveling out of the country, and whose medical history includes mild inflammatory bowel disease, which had not been diagnosed as either Crohn's disease or ulcerative colitis, had received her first dose of YF Vax vaccine, Typhim VI vaccine, poliomyelitis inactivated vaccine, and hep A vaccine on 01May06. On 03May06, the pt subsequently received additional immunizations with her first dose of Meningococcal vaccine and pneumococcal vaccine. The trade names, manf lot numbers, routes and sites of administration were not reported for any of the vaccines. Two hours post immunization on 03May06, the pt developed shaking chills, muscle aches, a sore neck and fever. She was seen in the ER and treated with IV fluids and an unk antibiotic. A CBC was completed and her WBC's were 12,000. Her chemistry test was normal, except for a low serum sodium level of 131. A lumbar puncture was not done. At the time of this report, the pt had been under observation in the ER for more than 24 hrs. The reporter stated that she was in the process of trying to get the pt transferred from the rural hospital ER to a higher level hospital. The reporter was concerned that the events were related to the YF Vax immunization. The pt had not recovered from these events at the time of this report.
Age: 48.0
Sex: F
Vaccine: HEPA, IPV, MEN, PPV, TYP, YF, HEPA, IPV, MNQ, PPV, TYP, HEPA, IPV, TYP, YF
Symptoms: Tremor, White blood cell count increased
Clinical narrative: Initial report received on 04May06 from a health care professional. A 48 yr old female pt, who was traveling out of the country, and whose medical history includes mild inflammatory bowel disease, which had not been diagnosed as either Crohn's disease or ulcerative colitis, had received her first dose of YF Vax vaccine, Typhim VI vaccine, poliomyelitis inactivated vaccine, and hep A vaccine on 01May06. On 03May06, the pt subsequently received additional immunizations with her first dose of Meningococcal vaccine and pneumococcal vaccine. The trade names, manf lot numbers, routes and sites of administration were not reported for any of the vaccines. Two hours post immunization on 03May06, the pt developed shaking chills, muscle aches, a sore neck and fever. She was seen in the ER and treated with IV fluids and an unk antibiotic. A CBC was completed and her WBC's were 12,000. Her chemistry test was normal, except for a low serum sodium level of 131. A lumbar puncture was not done. At the time of this report, the pt had been under observation in the ER for more than 24 hrs. The reporter stated that she was in the process of trying to get the pt transferred from the rural hospital ER to a higher level hospital. The reporter was concerned that the events were related to the YF Vax immunization. The pt had not recovered from these events at the time of this report.
Age: 44.0
Sex: F
Vaccine: HEP, TD, HEP, TD, HEP, TD
Symptoms: Bedridden, Complex regional pain syndrome, Condition aggravated, Dizziness, Hemiparesis
Clinical narrative: Complex regional pain syndrome, condition aggravated, mobility decreased, pain, weakness left or right side, injection site burning. Initial report received from another mfr. on 5/8/06, the reporter to this mfr being a health care professional. A 44 year old female pt, with a history of complex regional pain syndrome, who received an IM, LA, injection of Decavac; a Tuberculin skin test and an IM, RA, first dose injection of Engerix-B on 8/30/05. Immediately post-vax, the pt experienced a burning sensation at an unspecified injection site. Per the reporter, the burning sensation slowly progressed into limited mobility, pain and weakness of the right side of the body. The pt was wheelchair bound. She was examined by a physician who considered the vaccines to have caused pt's worsening complex regional pain syndrome and deemed the event disabling. There was improvement in the pt's mobility, but the right-sided weakness, pain and the overall worsening of complex regional pain syndrome were ongoing. The events were considered probably related to Engerix-B  and the tetanus diphtheria vaccine. At the time of the initial report, the pt had not recovered.
Age: 44.0
Sex: F
Vaccine: HEP, TD, HEP, TD, HEP, TD
Symptoms: Hypokinesia, Injection site pain, Injection site rash, Pain, Photophobia
Clinical narrative: Complex regional pain syndrome, condition aggravated, mobility decreased, pain, weakness left or right side, injection site burning. Initial report received from another mfr. on 5/8/06, the reporter to this mfr being a health care professional. A 44 year old female pt, with a history of complex regional pain syndrome, who received an IM, LA, injection of Decavac; a Tuberculin skin test and an IM, RA, first dose injection of Engerix-B on 8/30/05. Immediately post-vax, the pt experienced a burning sensation at an unspecified injection site. Per the reporter, the burning sensation slowly progressed into limited mobility, pain and weakness of the right side of the body. The pt was wheelchair bound. She was examined by a physician who considered the vaccines to have caused pt's worsening complex regional pain syndrome and deemed the event disabling. There was improvement in the pt's mobility, but the right-sided weakness, pain and the overall worsening of complex regional pain syndrome were ongoing. The events were considered probably related to Engerix-B  and the tetanus diphtheria vaccine. At the time of the initial report, the pt had not recovered.
Age: 44.0
Sex: F
Vaccine: HEP, TD, HEP, TD, HEP, TD
Symptoms: Swelling, Thermal burn
Clinical narrative: Complex regional pain syndrome, condition aggravated, mobility decreased, pain, weakness left or right side, injection site burning. Initial report received from another mfr. on 5/8/06, the reporter to this mfr being a health care professional. A 44 year old female pt, with a history of complex regional pain syndrome, who received an IM, LA, injection of Decavac; a Tuberculin skin test and an IM, RA, first dose injection of Engerix-B on 8/30/05. Immediately post-vax, the pt experienced a burning sensation at an unspecified injection site. Per the reporter, the burning sensation slowly progressed into limited mobility, pain and weakness of the right side of the body. The pt was wheelchair bound. She was examined by a physician who considered the vaccines to have caused pt's worsening complex regional pain syndrome and deemed the event disabling. There was improvement in the pt's mobility, but the right-sided weakness, pain and the overall worsening of complex regional pain syndrome were ongoing. The events were considered probably related to Engerix-B  and the tetanus diphtheria vaccine. At the time of the initial report, the pt had not recovered.
Age: 44.0
Sex: F
Vaccine: HEP, TD, HEP, TD, HEP, TD
Symptoms: Abasia, Anxiety, Difficulty in walking, Dyspepsia, Erythema
Clinical narrative: Complex regional pain syndrome, condition aggravated, mobility decreased, pain, weakness left or right side, injection site burning. Initial report received from another mfr. on 5/8/06, the reporter to this mfr being a health care professional. A 44 year old female pt, with a history of complex regional pain syndrome, who received an IM, LA, injection of Decavac; a Tuberculin skin test and an IM, RA, first dose injection of Engerix-B on 8/30/05. Immediately post-vax, the pt experienced a burning sensation at an unspecified injection site. Per the reporter, the burning sensation slowly progressed into limited mobility, pain and weakness of the right side of the body. The pt was wheelchair bound. She was examined by a physician who considered the vaccines to have caused pt's worsening complex regional pain syndrome and deemed the event disabling. There was improvement in the pt's mobility, but the right-sided weakness, pain and the overall worsening of complex regional pain syndrome were ongoing. The events were considered probably related to Engerix-B  and the tetanus diphtheria vaccine. At the time of the initial report, the pt had not recovered.
Age: 44.0
Sex: F
Vaccine: HEP, TD, HEP, TD, HEP, TD
Symptoms: Face oedema, Headache, Hepatocellular damage, Hypovitaminosis, Nausea
Clinical narrative: Complex regional pain syndrome, condition aggravated, mobility decreased, pain, weakness left or right side, injection site burning. Initial report received from another mfr. on 5/8/06, the reporter to this mfr being a health care professional. A 44 year old female pt, with a history of complex regional pain syndrome, who received an IM, LA, injection of Decavac; a Tuberculin skin test and an IM, RA, first dose injection of Engerix-B on 8/30/05. Immediately post-vax, the pt experienced a burning sensation at an unspecified injection site. Per the reporter, the burning sensation slowly progressed into limited mobility, pain and weakness of the right side of the body. The pt was wheelchair bound. She was examined by a physician who considered the vaccines to have caused pt's worsening complex regional pain syndrome and deemed the event disabling. There was improvement in the pt's mobility, but the right-sided weakness, pain and the overall worsening of complex regional pain syndrome were ongoing. The events were considered probably related to Engerix-B  and the tetanus diphtheria vaccine. At the time of the initial report, the pt had not recovered.